Health
Preclinical data for the COVID-19 vaccine candidate shows efficacy and benefits – AlKhaleej Today
Preclinical data for the COVID-19 vaccine candidate shows efficacy and benefits
Photo credit: CC0 Public Domain
A COVID-19 vaccine candidate that underwent extensive preclinical testing at the University of Alabama in Birmingham during the spring and summer shows strong preclinical immune responses including several that differentiate it from other COVID-19 vaccine approaches, according to a preprint stored in the BioRxiv repository differ this week.
Partial preclinical results were announced in July and August by Maryland-based Altimmune Inc., a clinical-stage biopharma…
-
Business19 hours agoThe pros and cons of buying CBA shares in September
-
Noosa News19 hours agoRent changes on way for hundreds of social housing recipients following government review
-
Business15 hours agoWhere will Berkshire Hathaway be in 1 year?
-
Noosa News17 hours agoPolice reject claims about detained protester; SEQ train lines to be disrupted; BlueCare to cut enrolled nurses